Cartujano-Barrera Francisco, Cox Lisa Sanderson, Catley Delwyn, Cai Xueya, Diaz Francisco J, Arana-Chicas Evelyn, Chávez-Iñiguez Arlette, Ogedegbe Chinwe, Graves Kristi D, Rivera M Patricia, Ponce Arturo, Ellerbeck Edward F, Cupertino Ana Paula
Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY.
Department of Population Health, University of Kansas Medical Center, Kansas City, KS.
Chest. 2025 Feb;167(2):619-629. doi: 10.1016/j.chest.2024.07.160. Epub 2024 Aug 10.
Latino adults experience multiple barriers to health care access and treatment that result in tobacco-related disparities. Mobile interventions have the potential to deliver smoking cessation treatment among Latino adults, who show the highest use rates of mobile technologies.
Is Decídetexto, a culturally accommodated mobile health intervention, more effective for smoking cessation compared with standard care among Latinx adults who smoke?
A two-arm parallel group randomized clinical trial was conducted in Kansas, New Jersey, and New York between October 2018 and September 2021. Eligible Latino adults who smoke (n = 457) were randomly assigned to Decídetexto or a standard care group. The primary outcome was biochemically verified 7-day smoking abstinence at week 24. Secondary outcomes included self-reported 7-day smoking abstinence at weeks 12 and 24 and uptake and adherence of nicotine replacement therapy (NRT).
Participants' mean age was 48.7 (SD, 11.1) years, 45.2% were female, and 50.3% smoked ≥ 10 cigarettes per day. Two hundred twenty-nine participants were assigned to Decídetexto and 228 to standard care. Treating those lost to follow-up as participants who continued smoking, 14.4% of participants in the Decídetexto group were biochemically verified abstinent at week 24 compared with 9.2% in the standard care group (OR, 1.66; 95% CI, 0.93-2.97; P = .09). Treating those lost to follow-up as participants who continued smoking, 34.1% of the participants in the Decídetexto group self-reported smoking abstinence at week 24 compared with 20.6% of participants in the standard care group (OR, 1.99; 95% CI, 1.31-3.03; P < .001). Analyzing only participants who completed the assessment at week 24, 90.6% (174/192) of participants in the Decídetexto group self-reported using NRT for at least 1 day compared with 70.2% (139/198) of participants in standard care (OR, 4.10; 95% CI, 2.31-7.28; P < .01).
Among Latino adults who smoke, the Decídetexto intervention was not associated with a statistically significant increase in biochemically verified abstinence at week 24. However, the Decídetexto intervention was associated with a statistically significant increase in self-reported 7-day smoking abstinence at weeks 12 and 24 and uptake of NRT. This randomized clinical trial provides encouragement for the use of Decídetexto for smoking cessation among Latino adults.
ClinicalTrials.gov identifier: NCT03586596.
拉丁裔成年人在获得医疗保健和治疗方面面临多重障碍，这导致了与烟草相关的差异。移动干预措施有可能为拉丁裔成年人提供戒烟治疗，而拉丁裔成年人的移动技术使用率最高。
对于吸烟的拉丁裔成年人，一种经过文化调适的移动健康干预措施“Decídetexto”与标准护理相比，在戒烟方面是否更有效？
2018年10月至2021年9月期间，在堪萨斯州、新泽西州和纽约州进行了一项双臂平行组随机临床试验。符合条件的吸烟拉丁裔成年人（n = 457）被随机分配到Decídetexto组或标准护理组。主要结局是在第24周时经生化验证的7天戒烟情况。次要结局包括在第12周和第24周时自我报告的7天戒烟情况以及尼古丁替代疗法（NRT）的使用和依从性。
参与者的平均年龄为48.7（标准差，11.1）岁，45.2%为女性，50.3%每天吸烟≥10支。229名参与者被分配到Decídetexto组，228名参与者被分配到标准护理组。将失访者视为继续吸烟者，Decídetexto组中14.4%的参与者在第24周时经生化验证已戒烟，而标准护理组为9.2%（比值比，1.66；95%置信区间，0.93 - 2.97；P = 0.09）。将失访者视为继续吸烟者，Decídetexto组中34.1%的参与者在第24周时自我报告已戒烟，而标准护理组为20.6%（比值比，1.99；95%置信区间，1.31 - 3.03；P < 0.
